AGM Statement

Tate & Lyle PLC
                  

CHAIRMAN'S AGM STATEMENT

At the Annual General Meeting of Tate & Lyle PLC to be held in London today, Sir
David Lees, Chairman, will make the following statement on current trading and
expansion projects:

'Trading has started strongly in the current financial year. The first quarter's
results were well ahead of those in the corresponding period, excluding the
benefit of reduced depreciation (£25 million on an annual basis) arising from
the impairment charge of £272 million taken last year. This was due mainly to a
continuation of the strong performance from Food & Industrial Ingredients
Americas and from sugar trading. Work on our appropriate response to the changes
in the EU Sugar Regime continues.

Across the business we have a number of expansion projects under way which will
stimulate longer term growth in our value added segment. Both of the expansions
at the McIntosh, Alabama SPLENDA® Sucralose facility have been completed on
time. The first of these is now operating at capacity and the second is in a
commissioning period that we expect to last for several months. Construction of
the new SPLENDA® Sucralose facility in Singapore remains on schedule for
mechanical completion in January 2007. The increased production capacity from
these investments will enable us to build further the customer base and SPLENDA®
Sucralose brand. We have specifically designed the Singapore plant with the
potential for its capacity to be doubled, if required.

Our new joint venture plant with DuPont to produce Bio-PDO(TM) from renewable
resources has also been completed on schedule and is being commissioned. This is
a unique plant, the first in the world to produce Bio-PDO(TM), and we expect
that commissioning and production ramp up will take some time to complete. We
remain excited about the longer term market for Bio-PDO(TM) which has potential
in markets as diverse as apparel, carpets, automotive and electronics.

Our other US expansion projects in Sagamore and Loudon and the recently
announced investment in a new corn-wet mill in Fort Dodge, Iowa continue to
progress satisfactorily. Total investment in these three projects will be some
£250 million. This reflects our firm commitment to deliver against our growth
strategy and in particular to grow the contribution from value added products.

We continue to view the future with confidence and remain committed to our
target for the profit contribution from total value added products to increase
by 30% in the year to March 2007 from the £161 million reported last year.'

For more information contact Tate & Lyle PLC:
Mark Robinson (Investor Relations) Tel: [phone]
Ferne Hudson (Press) Tel: [phone]

About Tate & Lyle: Tate & Lyle is a world leading manufacturer of renewable food
and industrial ingredients. It uses innovative technology to transform corn,
wheat and sugar into value-added ingredients for customers in the food,
beverage, pharmaceutical, cosmetic, paper, packaging and building industries.
The Company is a leader in cereal sweeteners and starches, sugar refining, value
added food and industrial ingredients, and citric acid. Tate & Lyle is the world
number-one in industrial starches and is the sole manufacturer of SPLENDA®
Sucralose.

Headquartered in London, Tate & Lyle is listed on the London Stock Exchange
under the symbol TATE.L. In the US its ADRs trade under TATYY. The Company
operates more than 65 production facilities in 29 countries, throughout Europe,
the Americas and South East Asia. It employs 7,000 people in its subsidiaries
with a further 4,800 employed in joint ventures. Sales in the year to 31 March
2006 totalled £3.7 billion. Additional information can be found on
www.tateandlyle.com.

SPLENDA® is a trademark of McNeil Nutritionals, LLC